Research interests

Optimal use of innovative therapies for autoimmune inflammatory diseases.

Disease areas most studied are rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).

Methodologies include investigator-initiated clinical trials, (international) registries, and studies based on direct patient contact.

Novel therapeutic strategies (e.g., treat-to-target, induction-maintenance), novel methods of doing clinical trials ('the learning healt care environment'), use of imaging in clinical care, are among the most noted recent topics of the research in my group.

specialisation

Rheumatology

Research output

  1. Tofacitinib versus Methotrexate in Rheumatoid Arthritis

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Research output: Contribution to journalArticleAcademicpeer-review

View all (481) »

ID: 100751